← Back to Search

Remote Intensive Outpatient Program for Opioid Use Disorder

N/A

Recruiting

Research Sponsored by Brigham and Women's Hospital

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Hospitalized for serious injection-related infection requiring long-term intravenous antibiotic treatment.

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 7-day follow up, 14-day follow up, 21-day follow up, and 28-day follow up

Awards & highlights

Study Summary

This trial will study if an online program can help decrease opioid use for hospitalized people with injection-related infections.

Who is the study for?

This trial is for English-speaking adults over 18 with severe opioid use disorder (OUD), currently hospitalized due to serious infections from injections, requiring long-term IV antibiotics. Participants must have at least two contacts for follow-up post-discharge.Check my eligibility

What is being tested?

The study tests a new 'SmartIOP' program delivered remotely to OUD patients in the hospital. It includes intensive outpatient treatment and support from a peer recovery coach, focusing on improving outcomes after leaving the hospital.See study design

What are the potential side effects?

Since this trial involves non-medical interventions like remote programs and coaching, traditional side effects are not expected. However, participants may experience emotional or psychological discomfort during therapy.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am in the hospital for a serious infection from an injection needing long-term IV antibiotics.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ immediately post intervention

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~immediately post intervention

This trial's timeline: 3 weeks for screening, Varies for treatment, and immediately post intervention for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Feasibility of the intervention program

Secondary outcome measures

Illicit opioid use

Retention with MOUD treatment

Trial Design

1Treatment groups

Experimental Treatment

Group I: Treatment GroupExperimental Treatment2 Interventions

The intervention to be developed and tested has two components: 1) the remotely delivered IOP ("Smart IOP"), and 2) a peer recovery coach to provide support and accountability to the participant.

0 / 1Eligibility criteria met

Find a Location

Who is running the clinical trial?

Brigham and Women's HospitalLead Sponsor

1,616 Previous Clinical Trials

11,470,928 Total Patients Enrolled

National Institute on Drug Abuse (NIDA)NIH

2,470 Previous Clinical Trials

2,619,711 Total Patients Enrolled

Mclean HospitalOTHER

213 Previous Clinical Trials

21,674 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there vacancies for individuals to participate in this clinical trial?

"According to clinicaltrials.gov, this research is in the process of enrolling participants. Initial advertisement for the trial was published on November 17th 2023 and pertinent updates were made four days later on the 21st."

Answered by AI

How many participants are involved in this experiment?

"Affirmative. Per information provided on clinicaltrials.gov, this research initiative is currently recruiting for candidates and was initially advertised on November 17th 2023. The most recent update to the trial's posting occurred on November 21st 2023; it requires a total of 20 enrollees from one site only."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Pilot Testing a Novel Remotely Delivered Intensive Outpatient Program for Individuals With OUD

Joji Suzuki, MD 2023. "Pilot Testing a Novel Remotely Delivered Intensive Outpatient Program for Individuals With OUD". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05817825.